APO Research
Talk to an analyst

APO RESEARCH · REPORT

Primary Antibody

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Primary Antibody Industry Growth and Trends Forecast to 2032

31 December 2025105 pages

Choose your research edition.

Industry ResearchPrimary Antibody Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Primary Antibody Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Primary Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Primary Antibody Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Primary Antibody Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Primary Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Primary Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Primary Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Primary Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Primary Antibody include Thermo Fisher Scientific, Roche Diagnostics, SouthernBiotech, Proteintech, OriGene, Novus Biologicals, HyTest, Genscript Biotech and Creative Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Primary Antibody market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Primary Antibody market size, estimates, and forecasts are presented in terms of sales volume (mg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Primary Antibody market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Primary Antibody.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Primary Antibody market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Primary Antibody Market by Company

Thermo Fisher Scientific

Roche Diagnostics

SouthernBiotech

Proteintech

OriGene

Novus Biologicals

HyTest

Genscript Biotech

Creative Diagnostics

Boster Bio

Biorbyt

Bio-Rad

Abcam

Primary Antibody Segment by Type

Monoclonal Antibodies

Polyclonal Antibody

Primary Antibody Segment by Application

Life Sciences

Laboratory

Hospital

Primary Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Primary Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Primary Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Primary Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Primary Antibody manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Primary Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Monoclonal Antibodies Table 2. Major Company of Polyclonal Antibody Table 3. Global Primary Antibody Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Primary Antibody Sales by Type (2021-2026) & (mg) Table 5. Global Primary Antibody Sales Market Share in Volume by Type (2021-2026) Table 6. Global Primary Antibody Sales by Type (2021-2026) & (US$ Million) Table 7. Global Primary Antibody Sales Market Share in Value by Type (2021-2026) Table 8. Global Primary Antibody Price by Type (2021-2026) & (US$/mg) Table 9. Global Primary Antibody Sales by Type (2027-2032) & (mg) Table 10. Global Primary Antibody Sales Market Share in Volume by Type (2027-2032) Table 11. Global Primary Antibody Sales by Type (2027-2032) & (US$ Million) Table 12. Global Primary Antibody Sales Market Share in Value by Type (2027-2032) Table 13. Global Primary Antibody Price by Type (2027-2032) & (US$/mg) Table 14. North America Primary Antibody Sales by Type (2021-2026) & (mg) Table 15. North America Primary Antibody Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Primary Antibody Sales by Type (2021-2026) & (mg) Table 17. Europe Primary Antibody Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Primary Antibody Sales by Type (2021-2026) & (mg) Table 19. Asia-Pacific Primary Antibody Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Primary Antibody Sales by Type (2021-2026) & (mg) Table 21. Latin America Primary Antibody Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Primary Antibody Sales by Type (2021-2026) & (mg) Table 23. Middle East and Africa Primary Antibody Sales by Type (2021-2026) & (US$ Million) Table 24. Primary Antibody Industry Trends Table 25. Primary Antibody Industry Drivers Table 26. Primary Antibody Industry Opportunities and Challenges Table 27. Primary Antibody Industry Restraints Table 28. Global Primary Antibody Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Primary Antibody Revenue Market Share by Company (2021-2026) Table 30. Global Primary Antibody Sales by Company (2021-2026) & (mg) Table 31. Global Primary Antibody Sales Share by Company (2021-2026) Table 32. Global Primary Antibody Market Price by Company (2021-2026) & (US$/mg) Table 33. Global Primary Antibody Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Primary Antibody Major Company Production Sites and Headquarters Table 35. Global Primary Antibody Company, Product Type & Application Table 36. Global Primary Antibody Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Primary Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Primary Antibody Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Primary Antibody Sales by Region (2021-2026) & (mg) Table 41. Global Primary Antibody Sales Market Share in Volume by Region (2021-2026) Table 42. Global Primary Antibody Sales by Region (2021-2026) & (US$ Million) Table 43. Global Primary Antibody Sales Market Share in Value by Region (2021-2026) Table 44. Global Primary Antibody Sales (mg), Value (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 45. Global Primary Antibody Sales by Region (2027-2032) & (mg) Table 46. Global Primary Antibody Sales Market Share in Volume by Region (2027-2032) Table 47. Global Primary Antibody Sales by Region (2027-2032) & (US$ Million) Table 48. Global Primary Antibody Sales Market Share in Value by Region (2027-2032) Table 49. Global Primary Antibody Sales (mg), Value (US$ Million), Price (US$/mg) and Gross Margin (2027-2032) Table 50. Global Primary Antibody Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Primary Antibody Sales by Application (2021-2026) & (mg) Table 52. Global Primary Antibody Sales Market Share in Volume by Application (2021-2026) Table 53. Global Primary Antibody Sales by Application (2021-2026) & (US$ Million) Table 54. Global Primary Antibody Sales Market Share in Value by Application (2021-2026) Table 55. Global Primary Antibody Price by Application (2021-2026) & (US$/mg) Table 56. Global Primary Antibody Sales by Application (2027-2032) & (mg) Table 57. Global Primary Antibody Sales Market Share in Volume by Application (2027-2032) Table 58. Global Primary Antibody Sales by Application (2027-2032) & (US$ Million) Table 59. Global Primary Antibody Sales Market Share in Value by Application (2027-2032) Table 60. Global Primary Antibody Price by Application (2027-2032) & (US$/mg) Table 61. North America Primary Antibody Sales by Application (2021-2026) & (mg) Table 62. North America Primary Antibody Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Primary Antibody Sales by Application (2021-2026) & (mg) Table 64. Europe Primary Antibody Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Primary Antibody Sales by Application (2021-2026) & (mg) Table 66. Asia-Pacific Primary Antibody Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Primary Antibody Sales by Application (2021-2026) & (mg) Table 68. Latin America Primary Antibody Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Primary Antibody Sales by Application (2021-2026) & (mg) Table 70. Middle East and Africa Primary Antibody Sales by Application (2021-2026) & (US$ Million) Table 71. Thermo Fisher Scientific Company Information Table 72. Thermo Fisher Scientific Business Overview Table 73. Thermo Fisher Scientific Primary Antibody Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 74. Thermo Fisher Scientific Primary Antibody Product Portfolio Table 75. Thermo Fisher Scientific Recent Development Table 76. Roche Diagnostics Company Information Table 77. Roche Diagnostics Business Overview Table 78. Roche Diagnostics Primary Antibody Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 79. Roche Diagnostics Primary Antibody Product Portfolio Table 80. Roche Diagnostics Recent Development Table 81. SouthernBiotech Company Information Table 82. SouthernBiotech Business Overview Table 83. SouthernBiotech Primary Antibody Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 84. SouthernBiotech Primary Antibody Product Portfolio Table 85. SouthernBiotech Recent Development Table 86. Proteintech Company Information Table 87. Proteintech Business Overview Table 88. Proteintech Primary Antibody Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 89. Proteintech Primary Antibody Product Portfolio Table 90. Proteintech Recent Development Table 91. OriGene Company Information Table 92. OriGene Business Overview Table 93. OriGene Primary Antibody Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 94. OriGene Primary Antibody Product Portfolio Table 95. OriGene Recent Development Table 96. Novus Biologicals Company Information Table 97. Novus Biologicals Business Overview Table 98. Novus Biologicals Primary Antibody Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 99. Novus Biologicals Primary Antibody Product Portfolio Table 100. Novus Biologicals Recent Development Table 101. HyTest Company Information Table 102. HyTest Business Overview Table 103. HyTest Primary Antibody Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 104. HyTest Primary Antibody Product Portfolio Table 105. HyTest Recent Development Table 106. Genscript Biotech Company Information Table 107. Genscript Biotech Business Overview Table 108. Genscript Biotech Primary Antibody Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 109. Genscript Biotech Primary Antibody Product Portfolio Table 110. Genscript Biotech Recent Development Table 111. Creative Diagnostics Company Information Table 112. Creative Diagnostics Business Overview Table 113. Creative Diagnostics Primary Antibody Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 114. Creative Diagnostics Primary Antibody Product Portfolio Table 115. Creative Diagnostics Recent Development Table 116. Boster Bio Company Information Table 117. Boster Bio Business Overview Table 118. Boster Bio Primary Antibody Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 119. Boster Bio Primary Antibody Product Portfolio Table 120. Boster Bio Recent Development Table 121. Biorbyt Company Information Table 122. Biorbyt Business Overview Table 123. Biorbyt Primary Antibody Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 124. Biorbyt Primary Antibody Product Portfolio Table 125. Biorbyt Recent Development Table 126. Bio-Rad Company Information Table 127. Bio-Rad Business Overview Table 128. Bio-Rad Primary Antibody Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 129. Bio-Rad Primary Antibody Product Portfolio Table 130. Bio-Rad Recent Development Table 131. Abcam Company Information Table 132. Abcam Business Overview Table 133. Abcam Primary Antibody Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 134. Abcam Primary Antibody Product Portfolio Table 135. Abcam Recent Development Table 136. North America Primary Antibody Market Size Growth Rate (CAGR) by Country (mg): 2021 VS 2025 VS 2032 Table 137. North America Primary Antibody Sales by Country (2021-2026) & (mg) Table 138. North America Primary Antibody Sales Market Share by Country (2021-2026) Table 139. North America Primary Antibody Sales Forecast by Country (2027-2032) & (mg) Table 140. North America Primary Antibody Sales Market Share Forecast by Country (2027-2032) Table 141. North America Primary Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Primary Antibody Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Primary Antibody Market Share by Country (2021-2026) Table 144. North America Primary Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Primary Antibody Market Share Forecast by Country (2027-2032) Table 146. Europe Primary Antibody Market Size Growth Rate (CAGR) by Country (mg): 2021 VS 2025 VS 2032 Table 147. Europe Primary Antibody Sales by Country (2021-2026) & (mg) Table 148. Europe Primary Antibody Sales Market Share by Country (2021-2026) Table 149. Europe Primary Antibody Sales Forecast by Country (2027-2032) & (mg) Table 150. Europe Primary Antibody Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Primary Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Primary Antibody Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Primary Antibody Market Share by Country (2021-2026) Table 154. Europe Primary Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Primary Antibody Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Primary Antibody Market Size Growth Rate (CAGR) by Country (mg): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Primary Antibody Sales by Country (2021-2026) & (mg) Table 158. Asia-Pacific Primary Antibody Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Primary Antibody Sales Forecast by Country (2027-2032) & (mg) Table 160. Asia-Pacific Primary Antibody Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Primary Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Primary Antibody Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Primary Antibody Market Share by Country (2021-2026) Table 164. Asia-Pacific Primary Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Primary Antibody Market Share Forecast by Country (2027-2032) Table 166. Latin America Primary Antibody Market Size Growth Rate (CAGR) by Country (mg): 2021 VS 2025 VS 2032 Table 167. Latin America Primary Antibody Sales by Country (2021-2026) & (mg) Table 168. Latin America Primary Antibody Sales Market Share by Country (2021-2026) Table 169. Latin America Primary Antibody Sales Forecast by Country (2027-2032) & (mg) Table 170. Latin America Primary Antibody Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Primary Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Primary Antibody Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Primary Antibody Market Share by Country (2021-2026) Table 174. Latin America Primary Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Primary Antibody Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Primary Antibody Market Size Growth Rate (CAGR) by Country (mg): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Primary Antibody Sales by Country (2021-2026) & (mg) Table 178. Middle East and Africa Primary Antibody Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Primary Antibody Sales Forecast by Country (2027-2032) & (mg) Table 180. Middle East and Africa Primary Antibody Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Primary Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Primary Antibody Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Primary Antibody Market Share by Country (2021-2026) Table 184. Middle East and Africa Primary Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Primary Antibody Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Primary Antibody Distributors List Table 189. Primary Antibody Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Primary Antibody Image Figure 2. Global Primary Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Primary Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global Primary Antibody Sales (2021-2032) & (mg) Figure 5. Monoclonal Antibodies Image Figure 6. Global Monoclonal Antibodies Sales YoY Growth (2021-2032) & (mg) Figure 7. Polyclonal Antibody Image Figure 8. Global Polyclonal Antibody Sales YoY Growth (2021-2032) & (mg) Figure 9. Global Primary Antibody Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Primary Antibody Market Share by Type 2025 VS 2032 Figure 11. North America Primary Antibody Sales Market Share in Volume by Type in 2025 Figure 12. North America Primary Antibody Sales Market Share in Value by Type in 2025 Figure 13. Europe Primary Antibody Sales Market Share in Volume by Type in 2025 Figure 14. Europe Primary Antibody Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Primary Antibody Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Primary Antibody Sales Market Share in Value by Type in 2025 Figure 17. Latin America Primary Antibody Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Primary Antibody Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Primary Antibody Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Primary Antibody Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Primary Antibody Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Life Sciences Image Figure 24. Global Life Sciences Sales YoY Growth (2021-2032) & (mg) Figure 25. Laboratory Image Figure 26. Global Laboratory Sales YoY Growth (2021-2032) & (mg) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (mg) Figure 29. Global Primary Antibody Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Primary Antibody Market Share by Application 2025 VS 2032 Figure 31. North America Primary Antibody Sales Market Share in Volume by Application in 2025 Figure 32. North America Primary Antibody Sales Market Share in Value by Application in 2025 Figure 33. Europe Primary Antibody Sales Market Share in Volume by Application in 2025 Figure 34. Europe Primary Antibody Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Primary Antibody Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Primary Antibody Sales Market Share in Value by Application in 2025 Figure 37. Latin America Primary Antibody Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Primary Antibody Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Primary Antibody Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Primary Antibody Sales Market Share in Value by Application in 2025 Figure 41. North America Primary Antibody Sales by Country: 2021 VS 2025 VS 2032 (mg) Figure 42. North America Primary Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Primary Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Primary Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Primary Antibody Sales by Country: 2021 VS 2025 VS 2032 (mg) Figure 46. Europe Primary Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Primary Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Primary Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Primary Antibody Sales by Country: 2021 VS 2025 VS 2032 (mg) Figure 50. Asia-Pacific Primary Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Primary Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Primary Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Primary Antibody Sales by Country: 2021 VS 2025 VS 2032 (mg) Figure 54. Latin America Primary Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Primary Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Primary Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Primary Antibody Sales by Country: 2021 VS 2025 VS 2032 (mg) Figure 58. Middle East and Africa Primary Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Primary Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Primary Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Primary Antibody Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Primary Antibody Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibodies
  • Polyclonal Antibody
Applications
  • Life Sciences
  • Laboratory
  • Hospital
Companies covered
  • Thermo Fisher Scientific
  • Roche Diagnostics
  • SouthernBiotech
  • Proteintech
  • OriGene
  • Novus Biologicals
  • HyTest
  • Genscript Biotech
  • Creative Diagnostics
  • Boster Bio
  • Biorbyt
  • Bio-Rad
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Primary Antibody Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Primary Antibody Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Primary Antibody Market by Type
  6. 1.3.1 Monoclonal Antibodies
  7. 1.3.2 Polyclonal Antibody
  8. 1.4 Global Primary Antibody Market Size by Type
  9. 1.4.1 Global Primary Antibody Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Primary Antibody Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Primary Antibody Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Primary Antibody Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Primary Antibody Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Primary Antibody Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Primary Antibody Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Primary Antibody Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Primary Antibody Industry Trends
  2. 2.2 Primary Antibody Industry Drivers
  3. 2.3 Primary Antibody Industry Opportunities and Challenges
  4. 2.4 Primary Antibody Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Primary Antibody Revenue (2021-2026)
  2. 3.2 Global Top Players by Primary Antibody Sales (2021-2026)
  3. 3.3 Global Top Players by Primary Antibody Price (2021-2026)
  4. 3.4 Global Primary Antibody Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Primary Antibody Major Company Production Sites & Headquarters
  6. 3.6 Global Primary Antibody Company, Product Type & Application
  7. 3.7 Global Primary Antibody Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Primary Antibody Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Primary Antibody Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Primary Antibody Tier 1, Tier 2, and Tier 3
4 Primary Antibody Regional Status and Outlook
  1. 4.1 Global Primary Antibody Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Primary Antibody Historic Market Size by Region
  3. 4.2.1 Global Primary Antibody Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Primary Antibody Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Primary Antibody Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Primary Antibody Forecasted Market Size by Region
  7. 4.3.1 Global Primary Antibody Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Primary Antibody Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Primary Antibody Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Primary Antibody by Application
  1. 5.1 Primary Antibody Market by Application
  2. 5.1.1 Life Sciences
  3. 5.1.2 Laboratory
  4. 5.1.3 Hospital
  5. 5.2 Global Primary Antibody Market Size by Application
  6. 5.2.1 Global Primary Antibody Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Primary Antibody Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Primary Antibody Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Primary Antibody Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Primary Antibody Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Primary Antibody Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Primary Antibody Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Primary Antibody Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific
  2. 6.1.1 Thermo Fisher Scientific Company Information
  3. 6.1.2 Thermo Fisher Scientific Business Overview
  4. 6.1.3 Thermo Fisher Scientific Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific Primary Antibody Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Recent Developments
  7. 6.2 Roche Diagnostics
  8. 6.2.1 Roche Diagnostics Company Information
  9. 6.2.2 Roche Diagnostics Business Overview
  10. 6.2.3 Roche Diagnostics Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Roche Diagnostics Primary Antibody Product Portfolio
  12. 6.2.5 Roche Diagnostics Recent Developments
  13. 6.3 SouthernBiotech
  14. 6.3.1 SouthernBiotech Company Information
  15. 6.3.2 SouthernBiotech Business Overview
  16. 6.3.3 SouthernBiotech Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 SouthernBiotech Primary Antibody Product Portfolio
  18. 6.3.5 SouthernBiotech Recent Developments
  19. 6.4 Proteintech
  20. 6.4.1 Proteintech Company Information
  21. 6.4.2 Proteintech Business Overview
  22. 6.4.3 Proteintech Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Proteintech Primary Antibody Product Portfolio
  24. 6.4.5 Proteintech Recent Developments
  25. 6.5 OriGene
  26. 6.5.1 OriGene Company Information
  27. 6.5.2 OriGene Business Overview
  28. 6.5.3 OriGene Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 OriGene Primary Antibody Product Portfolio
  30. 6.5.5 OriGene Recent Developments
  31. 6.6 Novus Biologicals
  32. 6.6.1 Novus Biologicals Company Information
  33. 6.6.2 Novus Biologicals Business Overview
  34. 6.6.3 Novus Biologicals Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novus Biologicals Primary Antibody Product Portfolio
  36. 6.6.5 Novus Biologicals Recent Developments
  37. 6.7 HyTest
  38. 6.7.1 HyTest Company Information
  39. 6.7.2 HyTest Business Overview
  40. 6.7.3 HyTest Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 HyTest Primary Antibody Product Portfolio
  42. 6.7.5 HyTest Recent Developments
  43. 6.8 Genscript Biotech
  44. 6.8.1 Genscript Biotech Company Information
  45. 6.8.2 Genscript Biotech Business Overview
  46. 6.8.3 Genscript Biotech Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Genscript Biotech Primary Antibody Product Portfolio
  48. 6.8.5 Genscript Biotech Recent Developments
  49. 6.9 Creative Diagnostics
  50. 6.9.1 Creative Diagnostics Company Information
  51. 6.9.2 Creative Diagnostics Business Overview
  52. 6.9.3 Creative Diagnostics Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Creative Diagnostics Primary Antibody Product Portfolio
  54. 6.9.5 Creative Diagnostics Recent Developments
  55. 6.10 Boster Bio
  56. 6.10.1 Boster Bio Company Information
  57. 6.10.2 Boster Bio Business Overview
  58. 6.10.3 Boster Bio Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Boster Bio Primary Antibody Product Portfolio
  60. 6.10.5 Boster Bio Recent Developments
  61. 6.11 Biorbyt
  62. 6.11.1 Biorbyt Company Information
  63. 6.11.2 Biorbyt Business Overview
  64. 6.11.3 Biorbyt Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Biorbyt Primary Antibody Product Portfolio
  66. 6.11.5 Biorbyt Recent Developments
  67. 6.12 Bio-Rad
  68. 6.12.1 Bio-Rad Company Information
  69. 6.12.2 Bio-Rad Business Overview
  70. 6.12.3 Bio-Rad Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Bio-Rad Primary Antibody Product Portfolio
  72. 6.12.5 Bio-Rad Recent Developments
  73. 6.13 Abcam
  74. 6.13.1 Abcam Company Information
  75. 6.13.2 Abcam Business Overview
  76. 6.13.3 Abcam Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Abcam Primary Antibody Product Portfolio
  78. 6.13.5 Abcam Recent Developments
7 North America by Country
  1. 7.1 North America Primary Antibody Sales by Country
  2. 7.1.1 North America Primary Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Primary Antibody Sales by Country (2021-2026)
  4. 7.1.3 North America Primary Antibody Sales Forecast by Country (2027-2032)
  5. 7.2 North America Primary Antibody Market Size by Country
  6. 7.2.1 North America Primary Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Primary Antibody Market Size by Country (2021-2026)
  8. 7.2.3 North America Primary Antibody Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Primary Antibody Sales by Country
  2. 8.1.1 Europe Primary Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Primary Antibody Sales by Country (2021-2026)
  4. 8.1.3 Europe Primary Antibody Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Primary Antibody Market Size by Country
  6. 8.2.1 Europe Primary Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Primary Antibody Market Size by Country (2021-2026)
  8. 8.2.3 Europe Primary Antibody Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Primary Antibody Sales by Country
  2. 9.1.1 Asia-Pacific Primary Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Primary Antibody Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Primary Antibody Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Primary Antibody Market Size by Country
  6. 9.2.1 Asia-Pacific Primary Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Primary Antibody Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Primary Antibody Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Primary Antibody Sales by Country
  2. 10.1.1 South America Primary Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Primary Antibody Sales by Country (2021-2026)
  4. 10.1.3 South America Primary Antibody Sales Forecast by Country (2027-2032)
  5. 10.2 South America Primary Antibody Market Size by Country
  6. 10.2.1 South America Primary Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Primary Antibody Market Size by Country (2021-2026)
  8. 10.2.3 South America Primary Antibody Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Primary Antibody Sales by Country
  2. 11.1.1 Middle East and Africa Primary Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Primary Antibody Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Primary Antibody Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Primary Antibody Market Size by Country
  6. 11.2.1 Middle East and Africa Primary Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Primary Antibody Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Primary Antibody Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Primary Antibody Value Chain Analysis
  2. 12.1.1 Primary Antibody Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Primary Antibody Production Mode & Process
  7. 12.2 Primary Antibody Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Primary Antibody Distributors
  10. 12.2.3 Primary Antibody Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst